Human IL-13Ra2 / CD213a2, His Tag

Reagent Code: #198262

blur_circular Chemical Specifications

inventory_2 Storage & Handling
Storage -20℃

description Product Description

Used in immunological research to study the role of IL-13 signaling in inflammatory diseases, particularly asthma and allergic responses. Serves as a capture antigen in ELISA and other immunoassays for detecting anti-IL-13Ra2 antibodies or measuring ligand binding affinity. Employed in protein-protein interaction studies due to its ability to bind IL-13 with high affinity. The His tag facilitates purification and detection in recombinant expression systems. Investigated as a potential target in cancer immunotherapy, especially in glioblastoma, where IL-13Ra2 is overexpressed on tumor cells. Supports development of monoclonal antibodies and chimeric antigen receptor (CAR) T-cell therapies targeting IL-13Ra2-positive tumors.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 50μg
10-20 days ฿11,410.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Human IL-13Ra2 / CD213a2, His Tag
No image available

Used in immunological research to study the role of IL-13 signaling in inflammatory diseases, particularly asthma and allergic responses. Serves as a capture antigen in ELISA and other immunoassays for detecting anti-IL-13Ra2 antibodies or measuring ligand binding affinity. Employed in protein-protein interaction studies due to its ability to bind IL-13 with high affinity. The His tag facilitates purification and detection in recombinant expression systems. Investigated as a potential target in cancer im

Used in immunological research to study the role of IL-13 signaling in inflammatory diseases, particularly asthma and allergic responses. Serves as a capture antigen in ELISA and other immunoassays for detecting anti-IL-13Ra2 antibodies or measuring ligand binding affinity. Employed in protein-protein interaction studies due to its ability to bind IL-13 with high affinity. The His tag facilitates purification and detection in recombinant expression systems. Investigated as a potential target in cancer immunotherapy, especially in glioblastoma, where IL-13Ra2 is overexpressed on tumor cells. Supports development of monoclonal antibodies and chimeric antigen receptor (CAR) T-cell therapies targeting IL-13Ra2-positive tumors.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...